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a b s t r a c t
In this review, we outline contemporary and upcoming electroanatomic technologies
focusing on new mapping tools especially in catheter ablation for atrial ﬁbrillation. The
number of catheter ablations has been increasing exponentially in the last few years due to
technological advancements enabling complex ablation strategies. The quality of the
contemporary systems of electroanatomic mapping is sufﬁciently high in terms of both
standard ablations, such as isolation of pulmonary veins, and evaluation and elimination of
complex arrhythmias. New instruments and devices are coming out to facilitate the process
of understanding arrhythmias and thus simplify their elimination. The trend shows a
deﬂection from ﬂuoroscopy towards more advanced technologies.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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In the last decade electroanatomical mapping systems have
noted a steep development. Currently they enable to generate
a 3D reconstruction of any part of heart without the need for a
ﬂuoroscopic navigation. Fluoroscopy is still a fundamental
instrument for displaying mapping and ablation catheters,
however, for a precise imaging of those structures that are
critical for eliminating complex arrhythmias it can be used
only in a limited scope [1] (Fig. 1). These systems, apart from
precise imaging of cardiac anatomy, position and movements
of catheters, are also valuable in terms of understanding the
mechanisms of arrhythmia. Thanks to integration of anatomic
and electrocardiographic (ECG) data they are very useful in
choosing an optimal location for ablation. Use of mapping
systems contributes to reducing the time of operation,
ﬂuoroscopy and radiofrequency delivery time [2].
Nowadays there are two mapping systems available for
performing catheter ablations: CARTO system (Biosense
Webster, Inc., Diamond Bar, CA) and EnSite Velocity cardiac
mapping system (St. Jude Medical, Inc., St. Paul, MN). In
both aforementioned cases the concept is based on a 3DFig. 1 – Fluoroscopy. Transseptal sheath with circular
mapping Lasso catheter in pulmonary vein. Decapolar
mapping catheter and ablation catheter in coronary sinus.
Biomonitor (implantable ECG recorder).reconstruction of the heart chamber being examined together
with imaging of mapping and ablation catheters.
CARTO
The CARTO mapping system uses low energy electromagnetic
ﬁelds. The coils emitting nonhomogenous magnetic ﬁeld
(3 coils with different weak magnetic ﬁelds – 5  106 to
5  105 Tesla) are located in a triangle (location pad) that is
placed under the table on which the patient lies during
ablation procedure. A magnetic sensor is in the catheter tip.
The evaluation of the magnetic ﬁeld strength and orientation
enables to localize catheter in space accurately. Patient's
motions cause inaccuracies in the already generated map,
thus previous generations of the CARTO system included a
reference pad placed on a patient's back within the range of
the electromagnetic ﬁeld. The last generation of the CARTO
system (CARTO3) combines the technology of magnetic and
impedance based catheters localization. Six electrode patches,
3 on patient's chest and 3 on the back, screen the current
emitted at a unique frequency from different catheter
electrodes (Figs. 2 and 3). Data from magnetic sensors are
rectiﬁed by impedance data to overcome distortions from non-
uniform intrathoracic resistances. Furthermore, this hybrid
method enhances the CARTO system accuracy and mainly
enables to display more catheters at a time. A 3D reconstruc-
tion of cardiac chambers can be generated by moving a
catheter in space (Fig. 4). Patient's movement or dislocation of
the location pad may lead to signiﬁcant map shifts that may be
uncorrectable. Space maps of the heart chambers are obtained
through an acquisition of points when a catheter is in touch
with endocardium (or epicardium in epicardial ablations), and
the greater the number of points acquired, the better the
anatomical detail obtained. The new CARTO system genera-
tion is capable of creating space maps using the so-called fast
anatomical mapping (FAM), continuous acquisition of points by a
simple movement of a catheter in individual heart chambers.
A drawback of the CARTO system is seen in its closed
architecture necessitating use of the original ablation catheter
with the magnetic sensor (e.g. Navistar, Biosense Webster,
Inc., Diamond Bar, CA, USA), since no map can be generated by
a catheter other than original.
EnSite NavX
EnSite NavX (the last version entitled EnSite Velocity) system is
based on use of body-surface patch electrodes. A high-
frequency (8 kHz) alternating current electrical signal is
delivered between pairs of patch electrodes. Intracardiac
Fig. 3 – CARTO electroanatomical system. Electrode patches
(3 on patient's back).
Fig. 4 – Workspace of technician operating
electroanatomical mapping system (CARTO3).
Fig. 2 – CARTO electroanatomical system. Electrode patches
(3 on patient's chest).
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on the catheters read relative voltages with respect to a
reference electrode and send the data to the computer for a
further processing. The position of the electrode, and thus the
catheter in space, is identiﬁed upon the analysis of voltages [3].
This makes a big difference in comparison with the CARTO
system (in CARTO speciﬁc patches see unique current from
electrodes in catheters, whereas in EnSite electrodes in
catheters see current delivered between patch electrode pairs).
The localization of catheters is calculated based on an
impedance gradient in relation to a reference electrode. These
calculations are often complicated by a non-linear impedance
of human body (impedance can alter during an operation).
This obstacle might be to some extent corrected by a process
called ﬁeld scaling. This adjusts for the non-linearity of the
geometry and takes into account the measured inter-electrode
spacing for all the locations within the geometry.
The Main advantage of the EnSite system over CARTO rests
in a visualization of multiple catheters from different
manufacturers, thanks to the open conﬁguration of the
system. All displayed catheters may be used for generating
a map. By moving a catheter in space we can create a 3D
reconstruction of cardiac chambers. The process of obtaining
anatomical data from all electrodes on any catheter can be
simultaneously connected with receiving electrophysiological
data. A 3D map is generated from individual points in space
and the electrocardiographic signals can be integrated into
this map (Fig. 5). In contrast to the CARTO system, EnSite
usually prefers a catheter placed at coronary sinus, which is
relatively stable, instead of extra-cardiac reference electrode.
Use of this intra-cardiac reference catheter improves the
compensation for cardiac and respiratory motion artefacts. A
problem occurs in the event of dislocation of the reference
catheter, which leads to uncorrectable map shifts.
Small single-centre studies comparing the two systems
head to head in atrial ﬁbrillation (AF) ablation therapy directly
demonstrated advantages of CARTO over EnSite NavX in terms
of ﬂuoroscopy use and procedure durations but with similar
clinical results [4,5].
Fig. 6 – CARTO electroanatomical mapping system. CARTO-
Merge – image integration (electroanatomical voltage map
and CT 3D-reconstruction of left atrium). Catheter ablation
for persistent atrial fibrillation. Red dots – ablation points.
Green dots – ablation points in coronary sinus. Orange dot –
oesophagus in close proximity with posterior wall of left
atrium.
Fig. 7 – CARTO electroanatomical mapping system. 3D
reconstruction of left atrium – CT image integration (CT
map only) Catheter ablation for persistent atrial fibrillation.
Red dots – ablation points. Green dots – ablation points in
coronary sinus. Orange dot – oesophagus in close
proximity with posterior wall of left atrium.
Fig. 5 – EnSite NavX. 3D reconstruction of left atrium. (A)
Ablation for paroxysmal atrial fibrillation. Red dots –
ablation points. (B) CT image integration.
Pictures courtesy of MUDr. Petr Peichl, Ph.D., IKEM, Prague.
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In most cases anatomical data from cardiac computed tomogra-
phy (CT), and (less frequently) magnetic resonance imaging (MRI),
acquired prior to performing the ablation, are used. These data
are processed and a 3D virtual CT map is made. The map
shows accurately individual structures and partial details such
as the pulmonary vein-atrial junction and the ridge between
left pulmonary veins and left atrial appendage with potential
anatomical variations. The 3D CT model serves at ﬁrst just as a
tool for orientation and anatomy assessment in order to
generate an electromagnetic map on which speciﬁc points are
subsequently deﬁned (e.g. the ridge between left pulmonary
veins, etc.) that are anchored to the relevant spot on the CT
map (Figs. 6 and 7). Both the CT and anatomical maps are then
either merged or fused together (for the CARTO system themodule is entitled CARTO-Merge). Hence ablation can be
carried out either on the map, which results from the fusion
of the CT and generated anatomical map, or only in the 3D CT
map that is precisely anchored in space. This integrating
enables us to increase the understanding of a patient's
complex atrial anatomy even more. For generating a detailed
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 7 0 – e 4 8 2e4743D anatomical map we can also use intracardiac echocardiogra-
phy (ICE). The CARTO system entails an option for using the
CARTO-Sound module which can be applied, by means of ICE,
for creating a 3D map through the combination of multiple 2D
ultrasound cross sections generated by the transducer.
However, the image integration has not proven any
unambiguous beneﬁt. The retrospective comparative studies
have documented reduced ﬂuoroscopy times, lower compli-
cation rates and even improved success rates [6]. Nonetheless,
these results have not been conﬁrmed in prospective studies
[7]. The great advantage of integrating an image with a precise
imaging method lies in displaying speciﬁc details of the
cardiac section accurately, showing anatomical variants with
a feasibility of an improved catheter contact in relatively
difﬁcult spots such as the ridge of the left pulmonary vein and
left atrial appendage. The setback is undoubtedly the price for
conducting the imaging method, its eventual radiation load
(CT) and potential complications caused by an allergic reaction
to the contrast medium being applied. Another fact to be taken
into consideration is that a virtual 3D reconstruction, same as
the point by point generated anatomical map, is just a static
representation of a moving organ. Not always are both maps
perfectly integrated, mainly due to different volumes during
CT and during the procedure. Nevertheless, many electro
physiologists use the image integration method in their
routine clinical practice just for its accuracy in anatomical
imaging.
Intracardiac echocardiography
Together with the electroanatomical mapping, ICE represents
an imaging modality having probably the biggest impact on
the procedure accuracy. Fluoroscopy is unable to display a
precise detail of a contact between a catheter and myocardium
(Fig. 8). A CT image, even though being accurate, is not always
perfectly integrated into the map for the reason of different
volumes of the speciﬁc cardiac section during CT and during
the ablation because of the patient's movements or inspiration
motions. Nor electrograms are deemed perfectly reliable forFig. 8 – Intracardiac echocardiography. Contact of ablation
catheter. Bubbles from catheter irrigation.assessing an accuracy of the catheter contact. ICE will always
localize the catheter precisely and reveal its relations to the
surrounding structures, so the method is in the high extent
capable to replace the CT reconstruction with its integration
with the anatomical map, as it enables us to carry out non-
ﬂuoroscopic real-time imaging of all important anatomical
structures and their potential anatomical variations. In real
time we can see all catheters and their contact with tissue as
well as their relation to a supporting sheath. Furthermore, we
are able to monitor the dangerous potentiality of a tissue
overheating accompanied by microbubbles and potentially
perilous steam pop that may be completely prevented by a
timely termination of ablation to avoid cardiac tamponade.
Having displayed the oesophagus, we can also avoid excessive
ablation in its vicinity and thus prevent atrio-oesophageal
ﬁstula formation but also the necessity of monitoring the
temperature in oesophagus during operation. By imagining of
antrum and ostia of pulmonary veins, we can avoid too deep
ablation and hence avoid the danger of pulmonary veins
stenosis completely. An ICE image clearly shows even small
thrombi that may be drained out, treated by coagulation and
thus thromboembolic complications can be prevented. An
eventual pericardial effusion can be noticed already in its early
stage when the volume of ﬂuid in pericardium is very low. Last
but not least, we have to highlight the fact that ICE enables us
to perform a safe transseptal puncture [8]. From the perspec-
tive of performing safe and effective ablations, ICE is probably
the most important imaging method. In spite of its high price
that may be viewed as a drawback, we are convinced that a
regular use of ICE, for its undisputed contribution to safety,
effectiveness and minimizing ﬂuoroscopy, shall be fully
justiﬁed.
Arrhythmia mapping with use of the
electroanatomical mapping system
The process is based on generating a 3D shell map of the heart
chamber in which the ablation shall be performed. The map is
created either manually point by point or simply by moving a
catheter without acquiring individual point (FAM) (Fig. 9). The
acquisition of points in any heart rhythm such as sinus
rhythm, atrial ﬁbrillation or other arrhythmias is connected
with automatic measurement of their voltages.
This voltage map enables us to assess eventual endocardial
and epicardial scars both primary, when the structure of
myocardium is afﬂicted (ﬁbrotic atrial remodelling, scar after
myocardial infarction, scar after cardiac surgery, myocardium
areas damaged by cardiomyopathy, etc.) or secondary,
following the already performed ablation. It is important to
mention that voltage mapping is inﬂuenced by heart rhythm
and tachycardia rate. The range of normal voltage for a bi-
polar voltage map is most commonly selected from 0.3 to
1.0 mV for atria and from 0.5 to 1.5 mV for ventricles (Fig. 10).
The areas indicating lower voltage will be shown in red and
are deemed to correspond to scar tissue. These areas enable
us to deﬁne those spots that are potentially signiﬁcant in
terms of arising and sustaining an arrhythmia even in its
absence. The atrial ﬁbrosis propensity is associated with a
worse post-ablation prognosis and can be also assessed from a
Fig. 11 – Activation map (CARTO). Map of left atrium after
pulmonary veins isolation, roof line and posterior mitral
line. Focal atrial tachycardia from left atrial appendage. Red
colour – earliest activation of left atrium, target for ablation.
Centrifugal activation, conduction block on ablation lines.Fig. 9 – CARTO electroanatomical mapping system. FAM
map (3D reconstruction of left atrium) + CT image
integration.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 7 0 – e 4 8 2 e475pre-ablation perspective. The DECAAF study demonstrated
that atrial tissue ﬁbrosis evaluated using late gadolinium
enhancement (LGE) MRI before ablation was in patients ablated
for AF an independent arrhythmia recurrence factor. The
extent of LGE predicted arrhythmia recurrence (15% for stage 1
ﬁbrosis (<10% of the atrial wall) to 69% for stage 4 ﬁbrosis (≥30%
of the atrial wall)) after 1–2 years [9]. Nonetheless the MRI
resolution values are still limiting for a real clinical practice,Fig. 10 – Voltage map (CARTO). Map of left atrium after
pulmonary veins isolation and a box lesion (exclusion of
posterior wall of left atrium). Red colour – areas indicating
low voltage (deemed to correspond to scar tissue). Violet
colour – areas with normal voltage (supposedly healthy
myocardium). Other colours – transient zone, areas with
lower voltage (possibly impaired myocardium).yet we can expect in the future that the advances in the ﬁeld of
MR spatial resolution will facilitate using this method in
clinical practice to deﬁne myocardial scarring even prior to
performing ablation, which could contribute to selecting right
patients for ablation, precise ablation targeting, or choosing
the correct range of ablation for each patient. For the time
being, MRI is used only before ablations of ventricular
tachycardias (regarding the bigger thickness of ventricular
walls in comparison with atrial) so as to deﬁne the myocardial
scar. Bearing in mind its low spatial resolution, this method
has not been hitherto used in practice prior to conducting
ablation of atrial ﬁbrillation. The future outlook promises the
integration of data from MRI (LGE) into an electroanatomical
map for a further imaging of areas, apart from voltage, aimed
potentially at the substrate modiﬁcation [10]. The LGE method
should be capable of revealing eventual gaps in the previous
ablation lines, albeit, regarding the capacity of contemporary
mapping methods (such as Lasso circular mapping catheter in
a pulmonary vein), this task is not very difﬁcult [11].
Activation mapping enables us to assess relative activation
time in a speciﬁc point in comparison with the reference while
tachycardia is in progress. As a reference for atrial tachyar-
rhythmia (AT) is used the signal from a stable catheter (most
frequently catheter in the coronary sinus) and the map of the
right or left atrium is being reconstructed point by point while
the activation time is measured precisely in each individual
point to calculate time difference in each point against the
stable reference (Fig. 11). Used as a reference in mapping
ventricular tachyarrhythmias is a QRS complex of surface ECG
(the complex with sharp R or S deﬂection is selected). The
character of signal propagation (i.e. activation of atria) helps us
to specify the mechanism of arrhythmia. The centrifugal
pattern is registered in case of focal tachycardia when ablation
in the earliest point enables us to terminate the arrhythmia
and eliminate its focal source. The wavefront activation with
circuit-like propagation pattern around an anatomical struc-
ture or a scar can be found in the case of macroreentry
Fig. 13 – Window of interest settings. Annotation of signal at
a point being examined (ablation catheter, MAP 1–2).
Reference signal in proximal coronary sinus (CS 9–10). WOI
(vertical lines) spans the whole tachycardia cycle.
Fig. 12 – Propagation map (CARTO). Map of left atrium after
pulmonary veins isolation, roof line and posterior mitral
line. Focal atrial tachycardia from left atrial appendage. Red
colour – activation of left atrium in one moment of time.
Centrifugal activation from left atrial appendage,
conduction block on ablation lines.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 7 0 – e 4 8 2e476tachycardia. The arrhythmia can be terminated and its
recurrence prevented through ablation in the point of critical
isthmus of arrhythmia, i.e. the area of a slow-pathway
conduction between 2 anatomical barriers. The ablation can
be visualized as a barrier put in a gorge between two
mountains to block any pathway that may lead through this
area deemed critical for sustaining arrhythmia. Relative time
(i.e. time difference between the activation time in a speciﬁc
point and in the reference signal) can be expressed in a variety
of colours so as to render a better view of each activated point
in the relevant heart chamber. A spread of electrical activation
on the two-coloured animated propagation map can be
displayed as soon as the activation map is completed
(Fig. 12). Use of activation mapping is difﬁcult in unstable
arrhythmias with a changing cycle length.
A necessary condition for generating an activation map that
can be evaluated and understood is setting the window of interest
(WOI) correctly (Fig. 13). The setting is different for atrial and
ventricular arrhythmias, and for focal and macroreentry
tachycardias. Should the WOI be set incorrectly in assessing a
ventricular tachycardia, the operator can become totally
perplexed and thus misunderstand the aetiology of arrhythmia.
For the focal AT the WOI is set so as to commence before the
beginning of P wave (ca 100 ms in advance). The most frequent
spot (red colour, ‘‘hot spot’’) represents the source of
tachycardia from which the signals propagate omnidirection-
ally in centrifugal pattern. The WOI does not need to contain
the entire length of a tachycardia cycle. In contrast, macro-
reentry tachycardias necessitates mapping of the whole
length cycle. The electrical wavefront circulates around an
obstacle. There is no site of earliest activation. The colours
smoothly and progressively change around the central
obstacle from the earliest to the latest activation. Most
operators set the WOI as simply as possible so that 50% of
tachyarrhythmia length cycle begins before the reference
signal (mostly the signal from the proximal CS) and 50% of TCL
length ends after the reference (TCL is simply divided into 2halves with the reference signal in the middle). The WOI, if set
randomly, shows indeed a ﬂuent change of colours, but the
points of the earliest and latest signal collisions will not make
any deeper sense. This spot (head meets tail) should ideally
coincide with the propagation of the activation wavefront
throughout the zone of slow conduction. According to Di Ponti
this optimal WOI setting (onset of the window is ﬁxed in mid-
diastole) for macroreentry tachycardias can be attained based
on this formula [12]:
Backward interval = (TCL  duration of P wave)/2 + Interval
from onset of P wave to reference signal (which has a
negative value when the reference signal precedes the P
wave onset)
Forward interval = (TCL  Backward interval)  0.9
The activation map, even though the setting seems at ﬁrst
glance a bit complicated (but in practice it takes several tens of
Fig. 15 – CARTO-PASO. Automatic comparison of QRS
complex morphology in a tachyarrhythmia/extrasystole
with the QRS complex during stimulation at any point in
the heart chamber being examined (Biosense Webster).
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 7 0 – e 4 8 2 e477seconds), not only shows the activation sequence, but also
directly indicates the critical area of the mid-diastolic narrow
isthmus (the place of the earliest and latest activation points,
red and purple). If turned out to be a focal arrhythmia, instead
of macroreentry, applying this formula does not lead to a
major mistake, since the centrifugal activation from the focal
point is clearly visible.
Nevertheless, in creating activation map it is indispensable
to avoid the sole reliance on annotation of signals. The key
principle rests in trying to understand the arrhythmia
mechanism through creation of a detailed voltage map
indicating fractionated and double potentials to enable us to
identify the zone of slow conduction and local lines of the
blockage. In many cases it is needless to create an activation
map if the operator is able to visualize mentally the signal
propagation (caudocranial, clockwise direction) in the largest
areas of the relevant heart chamber. This effort exerted for
understanding an arrhythmia without the toilsome process of
annotating each speciﬁc signal can still save a great deal of
time, in spite of all advanced imaging technologies (Fig. 14).
An enormously useful instrument to facilitate understand-
ing the distance of a speciﬁc point from an arrhythmia critical
spot is the entrainment mapping. Entrainment is simply a supra-
threshold pacing to the point whose distance from the
arrhythmia circuit shall be calculated by pacing with a little
higher speed than speed of arrhythmia (i.e. shorter cycle length
by 30–50 ms). If the pacing site lies within the arrhythmia circuit,
pacing speeds up the circulation without changing the
morphology of the P-waves or QRS complexes and other
intracardiac signals. In the event of an uninterrupted arrhyth-
mia, we will measure the interval from the last stimulus to the
ﬁrst following signal in the stimulated spot. This interval is
called post pacing interval (PPI). PPI should be identical in the cycle
length to that of the tachycardia. The longer PPI is in reference to
the TCL, the farther the calculated spot is found from the
arrhythmia circuit. So by means of the entrainment method we
can localize an approximate position of the arrhythmia circuit in
few steps and, consequently, the spot that is needed for itsFig. 14 – Intracardiac ECG. Atrial fibrillation in left superior
pulmonary vein antrum after isolation of all pulmonary
veins. Normal sinus rhythm, arrhythmia is entrapped in
isolated vein and is dissociated from the rest of the heart.
Blue – signals from circular Lasso catheter in pulmonary
vein. Green – atrial and ventricular signals from coronary
sinus.sustainment. The entrainment mapping can be also used in
case of focal tachyarrhythmias. However, systematic use of
entrainment mapping to deﬁne the reentry course and the
ablation target has several limitations. Stimulation may
terminate arrhythmia or cause degeneration into atrial ﬁbrilla-
tion. In regions with lower voltage it often cannot be performed
because of the lack of electrical capture. To prevent the
termination of an arrhythmia during entrainment pacing,
regions with fractionated signals should be annotated ﬁrst.
The operator should already have a vision of activation in the
examined heart chamber. In the process of generating an
activation map, it should already be completed.
When a traditional activation map is being generated, each
point is attributed time corresponding to the activation time
difference between the local point and the reference signal.
The values of individual points (and their colour representa-
tion) will continuously change in the arrhythmia circuit.
However, if the PPI measurement is carried out in more points,
the PPI value can be allotted manually to the point whose
stimulation brought about the acquired PPI value. The process
thus gives rise to the map of post pacing intervals when all points
in the circuit have the same colour (WOI start is set to 0
because, if PPI-TCL = 0, we are in the arrhythmia circuit).
A novelty in the ﬁeld of pace mapping is the capability of the
CARTO system to use the CARTO-PASO technology (Fig. 15).
The PASO is used for ablation of ventricular tachyarrhythmias,
including simple ventricular extrasystoles. The principle lies
in automatic comparison of QRS complex morphology in a
tachyarrhythmia/extrasystole with the QRS complex during
stimulation at any point in the heart chamber being examined.
This comparison is automatic and results not only in a
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 7 0 – e 4 8 2e478comprehensive view of even small differences in the local and
targeted QRS complex, but also in general percentage concor-
dance. The QRS complex when stimulated in the optimum
point for ablation reaches the closest match with the QRS in
arrhythmias.
Pace mapping is also used to deﬁne channels of slow conduction.
Ventricular tachycardia late after myocardial infarction is
usually due to reentry and is dependent on these channels.
Pace mapping in sinus rhythm provides a measure of slow
conduction, indicated by a long interval between the stimulus
and the onset of QRS complex (S-QRS).
Bearing in mind the effort aimed at understanding an
arrhythmia in activation mapping, the acquisition of points
through manual point-by-point annotation (when the signal
beginning is precisely indicated) is probably more accurate
than automatic algorithms, but the method is far from ﬂawless
and an eventual error in annotation cannot be excluded either,
especially in low voltage fragmented signals (that inundate the
atria in long-persistent atrial ﬁbrillation). In the event of
annotating a fragmented or double signal, only one concrete
signal beginning is annotated, so part of important informa-
tion is lost while generating an activation map for complex
signals. The new CARTO system technique, capable of imaging
the electrogram time-voltage data simultaneously as dynamic
bars on CARTO surface shells, was named Ripple mapping [13].
When this mapping technique is used, the electrograms are
displayed in the spatial map of a heart chamber as attached 3D
colour bars, instead of a simple point. In addition to localizing a
point on the map, the information on voltage–time relation-
ship can be added thanks to changing colours and dimensions
of these bars (which is, like in a standard activation mapping,
time-gated to a pre-selected reference electrogram). Just by
looking at these bars, without any annotation (manual or
automatic), we can see the signal propagation. Thus the entire
mapping process, alias the effort to understand the type of
arrhythmia, should be considerably simpliﬁed just by this
automatization. Unfortunately the maps are not created in
real time and the post-processing lasts a while. Despite this
limitation, the system should attain a higher diagnostic
accuracy than the conventional 3D mapping [14]. However
its beneﬁts for daily practice should be proven by a prospective
comparative study.
Another potentially promising and fast technique of
mapping arrhythmias is seen in Rhythmia (Boston Scientiﬁc,
Marlborough, Massachusetts, USA), the new electromagnetic
system. This system (like CARTO) is based on a magnetic
sensor at the catheter tip and impedance-based tracking. A
specially designed mini basket array with 8 splines, each
containing 8 electrodes attached to a bi-directional deﬂectable
catheter (IntellaMap Orion) can be used for automatic high
resolution mapping. Thus in total 64 electrodes are available for
assessing the signals and generating the map. Electroanato-
mical contact maps can be produced without the need for
extensive manual annotation very fast (a map with 4000
electrograms in 7 min in average) [15]. Apart from speed and
automatic annotation, another great advantage is a low level
of noise which enables to assess even very small signals in the
area of a scarred myocardium.
A separate chapter should be dedicated to mapping chaotic
signals during AF. For some time the signals during AF havebeen assessed on the basis of mapping complex fractionated atrial
electrograms (CFAEs). These electrograms are deﬁned as low
voltage (≤0.15 mV) multiple potential signals with one or both of
the following characteristics: [1] atrial EGMs composed of two
deﬂections or more, and/or perturbations of the baseline with
continuous deﬂection of a prolonged activation complex; [2]
atrial EGMs with a very short cycle length (≤120 ms), with or
without multiple potentials. CFAEs can be connected with
factors which perpetuate AF or be passive consequences of
rapid AF drivers originating elsewhere [16]. The CFAEs-based
ablation improves outcomes in patients with persistent and
long-lasting persistent AF [17]. CFAEs can be assessed automat-
ically and displayed in the electroanatomical map (CFAE-
CARTO) [18]. Nevertheless, no one has proven so far that
ablation assisted by this CFAEs automatic registration improves
the outcome when compared to conventional CFAE mapping
and ablation [19]. The CFAEs ablation is time consuming and
such a widespread treatment is often subsequently associated
with higher rates of post-procedural atrial tachycardias [20].
A new method of analyzing signals during atrial ﬁbrillation is
mapping of high dominant frequencies [21]. Using the high-
resolution signal analysis we should be able to reveal localized
reentrant sources of AF by following the signal propagation
known as rotors or focal impulses. The presence of these sources
results in a hierarchical distribution of frequencies throughout
the atria. High dominant frequency sites have more than 20%
frequency gradient relative to the surrounding tissue. These
dominant frequencies can be automatically displayed in the
contemporary electroanatomical systems and could represent
possible targets for ablation. As for paroxysmal AF, these areas
are often found in the pulmonary veins antra, whereas in
treating patients with persistent atrial ﬁbrillation they are
detected somewhere else in the atria outside the pulmonary
veins. We should bear in mind that even more such areas may
be found on one patient. According to initial studies, ablations
performed in these areas could organize or terminate the AF
[22].
A new system for analyzing signals in AF is RhythmView
mapping system (Topera, Menlo Park, CA, USA) which is based on
use of 64-pole basket catheters for automatic mapping of
many points during AF capable of creating AF propagation
maps. Focal impulses show centrifugal activation, rotors
should have stable spiral activation around a centre of
rotation. Usually 2–3 rotors or focal impulses can be
demonstrated in one patient. Ablation in these spots is the
foundation underlying the concept of focal impulse and rotor
modulation (FIRM) [23]. This mapping system is not used
separately, since isolation of pulmonary veins should be
completed after ablations carried out on these spots (using
CARTO or EnSite mapping systems). FIRM target sites can be
marked on the maps generated in these systems, so we can
avoid making a mistake in case of a basket catheter
dislocation. The question whether rotors can indeed be
localized so simply in running AF and the atrial ﬁbrillation
can be in most patients terminated or at least slowed down, or
eventually converted to AT, will be answered in the future as
well as the practical use of this system in reality. Financial
aspects should not be neglected either.
An attractive option is a non-invasive assessment of
mechanisms during AF by means of a new technology entitled
Fig. 16 – Measuring of Contact Force. SmartTouch catheter
(CARTO). Visualization of the extent of real-time contact in
grams (left upper corner) and catheter pressure vector
(arrow near catheter tip).
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at identifying drivers in persistent AF. It seems that persistent
AF in early months is maintained predominantly by drivers
clustered in a few regions, most of them being unstable
reentries, with a high rate of AF termination from limited
catheter ablation. Since the process of progressive remodelling
of atrial tissue is proportional to the duration of running AF, we
deem ideal to apply the mapping systems for an accurate
localization of a few target points when timely effect on AF is
exerted only by limited ablation. The current resolution of
body surface mapping has limited sensitivity in the case of
highly localized sources, small signals (<0.15 mV) and far-ﬁeld
signals, particularly in scar tissue [24].
Measuring of contact force
The cornerstone of an effective ablation with a subsequent
arrhythmia free follow up is achievement of transmural and
durable lesions. It is even more important to avoid excessive
contact to prevent severe complications. So far we cared mostly
about time and power of ablation. But a catheter stability and
adequate tissue contact are even more important. A useful
technique of great importance is visualizing the contact by ICE,
same as catheter movement along the structures clearly deﬁned
on a CT reconstruction. A minor aid, rather illusionary, is
contact perception of the catheter held in hand or catheter
movement on ﬂuoroscopy. Same inaccuracy in contact assess-
ment is shown by the intracardiac ECG signals and monitoring
impedance changes during ablation [25].
Notwithstanding, we are indeed able to measure precisely a
contact extent of the catheter with tissue and stability of the
catheter during ablation. The catheters being currently used to
measure the electrode contact with tissue are SmartTouch
catheter (Biosense Webster) for CARTO and TactiCath Quartz
catheter (St Jude Medical) for NavX (Fig. 16). Both systems
enable to measure a contact continuously, indicate the extent
of real-time contact in grams, display the catheter pressure
vector and time during which the catheter is in optimal
contact (optimal pressure is 10–30 g depending on the ablation
spot). The value of catheter pressure on tissue in grams, time
duration of this contact and eventual extent of contact
oscillation are displayed, like a force vector, on the CARTO
screen with an electroanatomical map. Contact force data are
depicted in a separate screen in the Ensite NavX system. In the
CARTO system, ablation points can be acquired automatically
depending on pre-deﬁned force-time integral (CARTO VisiTag).
Each ablation point has a colour-coded information about the
force and time applied in individual spots. This information
indicates if minimum criteria have been met (adequate force
with an increasing colour value based on time selected). Both
systems, in terms of their effectiveness and safety, have been
veriﬁed in prospective multicenter studies [26].
Integration of ﬂuoroscopic and non-ﬂuoroscopic
techniques
The MediGuide Technology (St Jude Medical) system allows for
visualization of small sensors which, due to their small size,can be embedded not only in catheters, but also in sheaths and
even in wires. The system is based on integration of
electroanatomical transmitters into an X-ray detector. The
combination of ﬂuoroscopy and magnetic tracking enables us
to register ﬂuoroscopic cine-loops and, subsequently, display
the catheters (or any sensor-equipped materials) over a pre-
recorded cine-loop. These cine-loops can change speed in
response to the patient's current pulse. The system allows for
a virtual biplane catheter visualization displaying two screens
with two different projections simultaneously. The MediGuide
system, combined with EnSite NavX, is capable to reduce
skiascopic time considerably. The system is free of any
signiﬁcant danger of complications, extended ablation, or its
deteriorated result [27]. However, total skiascopic time is
reduced in the event of an electrophysiologist who is still
dependent on ﬂuoroscopy mainly, yet electrophysiologists
turning to non-ﬂuoroscopic imaging methods (mainly ICE) will
hardly note any valuable difference, as the already short
skiascopic time is not dramatically reduced, but on the
contrary the total skiascopic dose is, with regard to the
angiography performed in left atrium during AF, higher than in
conventional ICE ablation.
The CARTO system has also the capability of integrating
electroanatomical mapping and live ﬂuoroscopy (CARTO-
UNIVU) into a single view (Fig. 17). Similar as the MediGuide
system, it allows for creating an electromagnetic map in the
background of an RTG image as well as simultaneous depiction
of two different projections on the same screen. This
integration eliminates the need for additional ﬂuoroscopy
Fig. 17 – CARTO-UNIVU. Integration of electroanatomical mapping and live fluoroscopy into a single view (Biosense Webster).
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used, as with MediGuide, a signiﬁcant reduction of skiascopic
time can be expected only in operators depending highly on
ﬂuoroscopy.
Multipolar mapping and ablation of atrial
ﬁbrillation
CARTO System also allows sampling multiple points of cardiac
mapping data simultaneously using PentaRay catheter. This
mapping catheter maps and records signals with high
resolution over a large area (Multi-Electrode Mapping – MEM).
This fast multi-electrode mapping can be used for atrial
tachycardias, ventricular tachycardias, and complex fraction-
ated electrograms in atrial ﬁbrillation. The aim is reduced
procedure and ﬂuoroscopy time. This new feature of CARTO
system (fast multi-electrode mapping) can be used also with
MEM versions of standard catheters (circular LassoNAV and
decapolar DecaNAV mapping catheters). Recently a CONFI-
DENSE mapping module for CARTO was introduced. This reﬁned
MEM mapping module, fully integrated into the CARTO
system, allows for automated point acquisition (when physi-
cian set-criteria are met) with automated point annotation.
Tissue proximity indication allows for proximity-based ﬁlter-
ing of points acquired with MEM catheters.
The dramatic increase in quantities of ablations for AF is in
parallel accompanied by the endeavour to simplify pulmonary
veins isolation. The non-irrigated duty-cycled bipolar and
unipolar radiofrequency ablation PVAC catheter (Medtronic,
Minneapolis, MN, USA) has been employed for some time, but
its use has been dramatically reduced after documenting a
high number of silent cerebral ischaemia, in comparison with
the standard cool-tip ablation catheter [28]. Recently, a newmultipolar (but this time open-irrigated) radiofrequency
ablation catheter nMARQ (Biosense-Webster) was introduced
[29]. This catheter can be visualized on an electroanatomical
map of CARTO system and can be used for ablation as well as
for mapping. It is equipped with a circular or semilunar distal
tip section that contains 10 platinum ring electrodes. Radio-
frequency energy generator delivers unipolar or bipolar
radiofrequency energy over multiple electrodes. Feasibility
and safety of ablation with this catheter has been shown in
patients with paroxysmal AF. However, issues regarding silent
cerebral ischaemia remain to be addressed [30].
Remotely controlled ablation systems
Both currently used remotely controlled systems are based on
the already existing systems of electroanatomical mapping.
The magnetic navigation system Niobe (Stereotaxis, St. Louis, MO,
USA) is integrated in CARTO-RMT system (it is also possible to
use it with EnSite NavX system). The Niobe system is
completely integrated into the electroanatomical system,
and a movement of catheter (i.e. movement of a magnetic
vector followed by the catheter movement) is controlled using
mouse. No other devices than those which are used for
working on an electroanatomical map are needed to bring
about a movement of the catheter. As results from a meta-
analysis of more than 900 patients, use of magnetic navigation
does not lead to a better clinical success rate. The fact is that a
lower amount of complications and reduced ﬂuoroscopic time
have been documented, yet at the cost of extended procedure
time and price of ablation [31].
The electromechanical robotic navigation system Sensei (Hansen
medical, Mountain View, CA, USA) is designed for use with
EnSite NavX. Neither a mouse nor the electroanatomical map
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the workstation simultaneously with the joystick controlling
the ablation catheter. The robotic system uses the Intellisense,
speciﬁc system for measuring the catheter contact force.
The biggest hurdle hindering use of these remotely
controlled ablation systems in practice is undoubtedly their
price in terms of both the purchase of the device and
disposable material costs. Another aspect to be taken into
consideration is the absence of superiority for these expensive
systems, in contrast to conventional manual ablations.
Mapping in electrophysiology and beyond –
coronary artery disease
The most common arrhythmias directly linked to coronary
artery disease (CAD) and to a history of myocardial infarction
(MI) are ventricular tachycardias. Mapping of these arrhyth-
mias is based on the before mentioned electrophysiological
principles (3D anatomic map, voltage, activation and entrain-
ment mapping) similar to supraventricular tachycardias
including atrial ﬁbrillation. Pace mapping is used in search
for focal premature ventricular beats from Purkinje system
triggering ventricular ﬁbrillation. MRI with LGE is used
extensively to deﬁne myocardial substrate before catheter
ablation.
A different approach is used in endomyocardial mapping
and stem cells delivery in patients with ischaemic heart failure
and refractory angina. Catheter-based delivery of stem cells to
the heart aims to repair or perhaps reverse the effects of
myocardial ischaemia and injury. For a direct intramyocardial
injection of progenitor cells a NOGA system (Biologics Delivery
Systems, Diamond Bar, CA, USA) can be used. This system
allows for a real time assessment of electrical (voltage map)
and mechanical (linear local shortening – wall motion)
parameters within the left ventricle (LV), enabling online
assessment of myocardial viability. It is based on CARTO XP
technology and allows for creation of a 3D map of LV. This map
is colour-coded to delineate regions of viable, ischaemic
myocardium. Map is created with a Myostar catheter. This
catheter is similar to a standard ablation CARTO Navistar
catheter with a sensor integrated within the distal tip of the
catheter, through which the injection needle is extended and
stem cells applied. Target areas can be precisely identiﬁed and
electronically marked with each injection. Although extensive
experience with this system has been accumulated in both
preclinical and clinical studies NOGA is still in the research
phase and is not commercially available so far [32,33].
Conclusion
The quality of the contemporary systems of electroanatomical
mapping is sufﬁciently high in terms of both standard ablations,
such as isolation of pulmonary veins, and evaluation and
elimination of complex tachyarrhythmias regardless of being
caused primarily by an impaired myocardium or as a conse-
quence of an extensive ablation. Nowadays new instruments
and devices are coming out to facilitate the process of
understanding arrhythmias and thus simplify their elimination.The trend apparently shows a deﬂection from ﬂuoroscopy
towards more advanced technologies aimed at maintaining
safety standards, higher speed and a better outcome of ablations
at hopefully reasonable purchase prices. The evaluation of
complex signals in running AF should lead in the future to an
improved ablation targeting. Assisted by automatic registration
of intracardiac electrograms and integration of other imaging
methods, even less experienced operators could be able to
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